{"id":33929,"date":"2025-06-12T10:00:00","date_gmt":"2025-06-12T08:00:00","guid":{"rendered":"https:\/\/mabdesign.fr\/?p=33929"},"modified":"2025-06-12T10:25:01","modified_gmt":"2025-06-12T08:25:01","slug":"zoom-on-visync","status":"publish","type":"post","link":"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/","title":{"rendered":"ZOOM ON &#8211; Visync"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"33929\" class=\"elementor elementor-33929\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4e54fe81 e-flex e-con-boxed e-con e-parent\" data-id=\"4e54fe81\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-414cf62f e-con-full e-flex e-con e-child\" data-id=\"414cf62f\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1dad6a54 elementor-widget__width-initial elementor-widget elementor-widget-image\" data-id=\"1dad6a54\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"800\" height=\"452\" src=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/Logo-Visync-500x282_Plan-de-travail-1-1024x578.jpg\" class=\"attachment-large size-large wp-image-33940\" alt=\"\" srcset=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/Logo-Visync-500x282_Plan-de-travail-1-1024x578.jpg 1024w, https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/Logo-Visync-500x282_Plan-de-travail-1-300x169.jpg 300w, https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/Logo-Visync-500x282_Plan-de-travail-1-768x433.jpg 768w, https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/Logo-Visync-500x282_Plan-de-travail-1-1536x866.jpg 1536w, https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/Logo-Visync-500x282_Plan-de-travail-1-2048x1155.jpg 2048w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-20c038d0 e-con-full e-flex e-con e-child\" data-id=\"20c038d0\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5b4312d8 elementor-widget elementor-widget-heading\" data-id=\"5b4312d8\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">Who are you?<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5d0556b1 elementor-widget elementor-widget-text-editor\" data-id=\"5d0556b1\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><b>ViSync<\/b><b> Technologies<\/b> is a research, pre-clinical development company, in the field of new therapeutic modalities, aiming to develop technology platforms to solve current challenges in the fields of stability, targeting &amp; delivery of these therapies, including cell and gene therapies.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-393e8252 e-flex e-con-boxed e-con e-parent\" data-id=\"393e8252\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7cf69bbb elementor-widget elementor-widget-text-editor\" data-id=\"7cf69bbb\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p># Formulation<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4966d1c8 elementor-widget elementor-widget-text-editor\" data-id=\"4966d1c8\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p># Delivery<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-150b3800 elementor-widget elementor-widget-text-editor\" data-id=\"150b3800\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p># Innovation<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-7c6810f1 e-flex e-con-boxed e-con e-parent\" data-id=\"7c6810f1\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6f247d6b elementor-widget elementor-widget-heading\" data-id=\"6f247d6b\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">What is your expertise?<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5ab4ede3 elementor-widget elementor-widget-text-editor\" data-id=\"5ab4ede3\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>We are scientists and innovators united by a shared commitment to advancing the future of medicine by tackling formulation and delivery challenges. With deep knowledge of science, regulation, and market needs, in advanced therapies, such as cell and gene therapies, we aim to accelerate innovation through technology and science-driven solutions.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-47e26d78 e-flex e-con-boxed e-con e-parent\" data-id=\"47e26d78\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-36705aaa elementor-widget elementor-widget-heading\" data-id=\"36705aaa\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">What are your key products or services?<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-41a84801 elementor-widget elementor-widget-text-editor\" data-id=\"41a84801\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>All our activities are focused on formulation and delivery innovation, to empower pharma developers with expert insights, data, and strategic support. From formulation to commercialization, we help you overcome stability and targeting challenges and bring advanced therapies to patients, faster and more effectively.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1a1bf708 elementor-align-center elementor-widget elementor-widget-button\" data-id=\"1a1bf708\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/ZOOM-ON-LinkedIn-ViSync_brand-reviewed.pdf\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Download the ZOOM ON<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6c1f0638 e-flex e-con-boxed e-con e-parent\" data-id=\"6c1f0638\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;gradient&quot;,&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-492d6402 e-con-full e-flex e-con e-child\" data-id=\"492d6402\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2dd87113 elementor-widget elementor-widget-heading\" data-id=\"2dd87113\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">Vous souhaitez en savoir plus? <\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-5957a90b e-con-full e-flex e-con e-child\" data-id=\"5957a90b\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t<div class=\"elementor-element elementor-element-3c501167 e-con-full e-flex e-con e-child\" data-id=\"3c501167\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-739c202a elementor-widget elementor-widget-text-editor\" data-id=\"739c202a\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><b>Elsa A<\/b><b>BRANCHES<\/b><\/p><p>Chief Scientific Officer<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-397a4f80 e-con-full e-flex e-con e-child\" data-id=\"397a4f80\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-41693265 elementor-widget__width-initial elementor-view-default elementor-widget elementor-widget-icon\" data-id=\"41693265\" data-element_type=\"widget\" data-widget_type=\"icon.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon-wrapper\">\n\t\t\t<div class=\"elementor-icon\">\n\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-envelope\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M502.3 190.8c3.9-3.1 9.7-.2 9.7 4.7V400c0 26.5-21.5 48-48 48H48c-26.5 0-48-21.5-48-48V195.6c0-5 5.7-7.8 9.7-4.7 22.4 17.4 52.1 39.5 154.1 113.6 21.1 15.4 56.7 47.8 92.2 47.6 35.7.3 72-32.8 92.3-47.6 102-74.1 131.6-96.3 154-113.7zM256 320c23.2.4 56.6-29.2 73.4-41.4 132.7-96.3 142.8-104.7 173.4-128.7 5.8-4.5 9.2-11.5 9.2-18.9v-19c0-26.5-21.5-48-48-48H48C21.5 64 0 85.5 0 112v19c0 7.4 3.4 14.3 9.2 18.9 30.6 23.9 40.7 32.4 173.4 128.7 16.8 12.2 50.2 41.8 73.4 41.4z\"><\/path><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3f582288 elementor-widget elementor-widget-text-editor\" data-id=\"3f582288\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>eabranches@visync.com<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-84ec90a e-con-full e-flex e-con e-child\" data-id=\"84ec90a\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2a4dd73d elementor-widget__width-initial elementor-view-default elementor-widget elementor-widget-icon\" data-id=\"2a4dd73d\" data-element_type=\"widget\" data-widget_type=\"icon.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-icon-wrapper\">\n\t\t\t<div class=\"elementor-icon\">\n\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-phone-alt\" viewBox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M497.39 361.8l-112-48a24 24 0 0 0-28 6.9l-49.6 60.6A370.66 370.66 0 0 1 130.6 204.11l60.6-49.6a23.94 23.94 0 0 0 6.9-28l-48-112A24.16 24.16 0 0 0 122.6.61l-104 24A24 24 0 0 0 0 48c0 256.5 207.9 464 464 464a24 24 0 0 0 23.4-18.6l24-104a24.29 24.29 0 0 0-14.01-27.6z\"><\/path><\/svg>\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-76bdeda5 elementor-widget elementor-widget-text-editor\" data-id=\"76bdeda5\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>+351 910 307 104<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-46ae4189 elementor-widget elementor-widget-text-editor\" data-id=\"46ae4189\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><b>www.visync.com<\/b><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6723927e e-con-full e-flex e-con e-child\" data-id=\"6723927e\" data-element_type=\"container\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4860d6b9 elementor-widget elementor-widget-image\" data-id=\"4860d6b9\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"800\" height=\"452\" src=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/Logo-Visync-500x282_Plan-de-travail-1-1-1024x578.jpg\" class=\"attachment-large size-large wp-image-33942\" alt=\"\" srcset=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/Logo-Visync-500x282_Plan-de-travail-1-1-1024x578.jpg 1024w, https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/Logo-Visync-500x282_Plan-de-travail-1-1-300x169.jpg 300w, https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/Logo-Visync-500x282_Plan-de-travail-1-1-768x433.jpg 768w, https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/Logo-Visync-500x282_Plan-de-travail-1-1-1536x866.jpg 1536w, https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/Logo-Visync-500x282_Plan-de-travail-1-1-2048x1155.jpg 2048w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3d1cb1f elementor-widget elementor-widget-text-editor\" data-id=\"3d1cb1f\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Member of<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3f44da55 elementor-widget elementor-widget-image\" data-id=\"3f44da55\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"800\" height=\"236\" src=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/12\/22-05-17_LOGO-MABDESIGN-22-BLANC.png\" class=\"attachment-large size-large wp-image-26615\" alt=\"MabDesign\" srcset=\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/12\/22-05-17_LOGO-MABDESIGN-22-BLANC.png 819w, https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/12\/22-05-17_LOGO-MABDESIGN-22-BLANC-300x89.png 300w, https:\/\/mabdesign.fr\/wp-content\/uploads\/2024\/12\/22-05-17_LOGO-MABDESIGN-22-BLANC-768x227.png 768w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>ViSync Technologies is a research, pre-clinical development company, in the field of new therapeutic modalities, aiming to develop technology platforms to solve current challenges in the fields of stability, targeting &#038; delivery of these therapies, including cell and gene therapies. <\/p>\n","protected":false},"author":6,"featured_media":33934,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9,11],"tags":[343,342,94],"class_list":["post-33929","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites","category-zoom-on","tag-delivery","tag-formulation","tag-innovation"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ZOOM ON - Visync - MabDesign<\/title>\n<meta name=\"description\" content=\"ViSync Technologies is a research, pre-clinical development company, in the field of new therapeutic modalities, aiming to develop technology platforms to solve current challenges in the fields of stability, targeting &amp; delivery of these therapies, including cell and gene therapies. ViSync Technologies is a research, pre-clinical development company, in the field of new therapeutic modalities, aiming to develop technology platforms to solve current challenges in the fields of stability, targeting &amp; delivery of these therapies, including cell and gene therapies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ZOOM ON - Visync - MabDesign\" \/>\n<meta property=\"og:description\" content=\"ViSync Technologies is a research, pre-clinical development company, in the field of new therapeutic modalities, aiming to develop technology platforms to solve current challenges in the fields of stability, targeting &amp; delivery of these therapies, including cell and gene therapies. ViSync Technologies is a research, pre-clinical development company, in the field of new therapeutic modalities, aiming to develop technology platforms to solve current challenges in the fields of stability, targeting &amp; delivery of these therapies, including cell and gene therapies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/\" \/>\n<meta property=\"og:site_name\" content=\"MabDesign\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-12T08:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-12T08:25:01+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/1ere-slide-Visync-1-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2062\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Maissa Pote\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:site\" content=\"@MabDesign_fr\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maissa Pote\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/\"},\"author\":{\"name\":\"Maissa Pote\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/dadad49556eefa9f367253af9f8e4029\"},\"headline\":\"ZOOM ON &#8211; Visync\",\"datePublished\":\"2025-06-12T08:00:00+00:00\",\"dateModified\":\"2025-06-12T08:25:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/\"},\"wordCount\":177,\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/1ere-slide-Visync-1-scaled.jpg\",\"keywords\":[\"Delivery\",\"Formulation\",\"innovation\"],\"articleSection\":[\"Actualit\u00e9s\",\"ZOOM ON -\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/\",\"url\":\"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/\",\"name\":\"ZOOM ON - Visync - MabDesign\",\"isPartOf\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/1ere-slide-Visync-1-scaled.jpg\",\"datePublished\":\"2025-06-12T08:00:00+00:00\",\"dateModified\":\"2025-06-12T08:25:01+00:00\",\"description\":\"ViSync Technologies is a research, pre-clinical development company, in the field of new therapeutic modalities, aiming to develop technology platforms to solve current challenges in the fields of stability, targeting & delivery of these therapies, including cell and gene therapies. ViSync Technologies is a research, pre-clinical development company, in the field of new therapeutic modalities, aiming to develop technology platforms to solve current challenges in the fields of stability, targeting & delivery of these therapies, including cell and gene therapies.\",\"breadcrumb\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/#primaryimage\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/1ere-slide-Visync-1-scaled.jpg\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/1ere-slide-Visync-1-scaled.jpg\",\"width\":2062,\"height\":2560},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/mabdesign.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ZOOM ON &#8211; Visync\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#website\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"name\":\"Mabdesign\",\"description\":\"The Biotherapy Expert\",\"publisher\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/mabdesign.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#organization\",\"name\":\"Mabdesign\",\"url\":\"https:\/\/mabdesign.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"contentUrl\":\"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png\",\"width\":786,\"height\":233,\"caption\":\"Mabdesign\"},\"image\":{\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/MabDesign_fr\",\"https:\/\/www.linkedin.com\/company\/mabdesign\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/dadad49556eefa9f367253af9f8e4029\",\"name\":\"Maissa Pote\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c0a02ac51ae23c4db179e2854e03e397b7afe326a9890c70d0f3b22cd90aac1d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c0a02ac51ae23c4db179e2854e03e397b7afe326a9890c70d0f3b22cd90aac1d?s=96&d=mm&r=g\",\"caption\":\"Maissa Pote\"},\"url\":\"https:\/\/mabdesign.fr\/en\/author\/communication\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ZOOM ON - Visync - MabDesign","description":"ViSync Technologies is a research, pre-clinical development company, in the field of new therapeutic modalities, aiming to develop technology platforms to solve current challenges in the fields of stability, targeting & delivery of these therapies, including cell and gene therapies. ViSync Technologies is a research, pre-clinical development company, in the field of new therapeutic modalities, aiming to develop technology platforms to solve current challenges in the fields of stability, targeting & delivery of these therapies, including cell and gene therapies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/","og_locale":"en_US","og_type":"article","og_title":"ZOOM ON - Visync - MabDesign","og_description":"ViSync Technologies is a research, pre-clinical development company, in the field of new therapeutic modalities, aiming to develop technology platforms to solve current challenges in the fields of stability, targeting & delivery of these therapies, including cell and gene therapies. ViSync Technologies is a research, pre-clinical development company, in the field of new therapeutic modalities, aiming to develop technology platforms to solve current challenges in the fields of stability, targeting & delivery of these therapies, including cell and gene therapies.","og_url":"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/","og_site_name":"MabDesign","article_published_time":"2025-06-12T08:00:00+00:00","article_modified_time":"2025-06-12T08:25:01+00:00","og_image":[{"width":2062,"height":2560,"url":"http:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/1ere-slide-Visync-1-scaled.jpg","type":"image\/jpeg"}],"author":"Maissa Pote","twitter_card":"summary_large_image","twitter_creator":"@MabDesign_fr","twitter_site":"@MabDesign_fr","twitter_misc":{"Written by":"Maissa Pote","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/#article","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/"},"author":{"name":"Maissa Pote","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/dadad49556eefa9f367253af9f8e4029"},"headline":"ZOOM ON &#8211; Visync","datePublished":"2025-06-12T08:00:00+00:00","dateModified":"2025-06-12T08:25:01+00:00","mainEntityOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/"},"wordCount":177,"publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/1ere-slide-Visync-1-scaled.jpg","keywords":["Delivery","Formulation","innovation"],"articleSection":["Actualit\u00e9s","ZOOM ON -"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/","url":"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/","name":"ZOOM ON - Visync - MabDesign","isPartOf":{"@id":"https:\/\/mabdesign.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/#primaryimage"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/#primaryimage"},"thumbnailUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/1ere-slide-Visync-1-scaled.jpg","datePublished":"2025-06-12T08:00:00+00:00","dateModified":"2025-06-12T08:25:01+00:00","description":"ViSync Technologies is a research, pre-clinical development company, in the field of new therapeutic modalities, aiming to develop technology platforms to solve current challenges in the fields of stability, targeting & delivery of these therapies, including cell and gene therapies. ViSync Technologies is a research, pre-clinical development company, in the field of new therapeutic modalities, aiming to develop technology platforms to solve current challenges in the fields of stability, targeting & delivery of these therapies, including cell and gene therapies.","breadcrumb":{"@id":"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mabdesign.fr\/en\/zoom-on-visync\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/#primaryimage","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/1ere-slide-Visync-1-scaled.jpg","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2025\/06\/1ere-slide-Visync-1-scaled.jpg","width":2062,"height":2560},{"@type":"BreadcrumbList","@id":"https:\/\/mabdesign.fr\/en\/zoom-on-visync\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/mabdesign.fr\/en\/"},{"@type":"ListItem","position":2,"name":"ZOOM ON &#8211; Visync"}]},{"@type":"WebSite","@id":"https:\/\/mabdesign.fr\/en\/#website","url":"https:\/\/mabdesign.fr\/en\/","name":"Mabdesign","description":"The Biotherapy Expert","publisher":{"@id":"https:\/\/mabdesign.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mabdesign.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/mabdesign.fr\/en\/#organization","name":"Mabdesign","url":"https:\/\/mabdesign.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","contentUrl":"https:\/\/mabdesign.fr\/wp-content\/uploads\/2022\/11\/logo-mabdesign.png","width":786,"height":233,"caption":"Mabdesign"},"image":{"@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/MabDesign_fr","https:\/\/www.linkedin.com\/company\/mabdesign\/"]},{"@type":"Person","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/dadad49556eefa9f367253af9f8e4029","name":"Maissa Pote","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/mabdesign.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c0a02ac51ae23c4db179e2854e03e397b7afe326a9890c70d0f3b22cd90aac1d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c0a02ac51ae23c4db179e2854e03e397b7afe326a9890c70d0f3b22cd90aac1d?s=96&d=mm&r=g","caption":"Maissa Pote"},"url":"https:\/\/mabdesign.fr\/en\/author\/communication\/"}]}},"_links":{"self":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/33929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/comments?post=33929"}],"version-history":[{"count":13,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/33929\/revisions"}],"predecessor-version":[{"id":34009,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/posts\/33929\/revisions\/34009"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media\/33934"}],"wp:attachment":[{"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/media?parent=33929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/categories?post=33929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mabdesign.fr\/en\/wp-json\/wp\/v2\/tags?post=33929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}